Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jon Congleton currently holds 603,621 shares of Nivalis Therapeutics, Inc. (NVLS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jon Congleton has been a net seller of NVLS stock. They have purchased $208.4K and sold $12.4M worth of shares.
Jon Congleton's most recent insider trade was on Jul 13, 2026, when they sold 10,700 shares at $27.24 per share.
Jon Congleton serves as Executive at Nivalis Therapeutics, Inc. (NVLS). They have executed 31 insider transactions totaling $12.6M over their tenure at the company.
Jon Congleton holds the position of Executive at Nivalis Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Jon Congleton has shown a selling trading pattern, with $208.4K in total purchases and $12.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jon Congleton was on Nov 11, 2025, when they sold $5.1M worth of MLYS shares. This transaction involved 112,275 shares at $45.83 per share.
Jon Congleton currently owns 603,621 shares of Nivalis Therapeutics, Inc. (NVLS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jon Congleton's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jon Congleton has 31 Form 4 filings on record as an insider at Nivalis Therapeutics, Inc..
Set alerts for Jon Congleton and 40,000+ other insiders.